Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Depletion of Fumarate Hydratase, an Essential TCA Cycle Enzyme, Drives Proliferation in a Two-Step Model. | Cancers (Basel) | 2022 | 36428601 | PubTator, text mining | PubMed |
| Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma. | Biomedicines | 2022 | 36428491 | PubTator, text mining | PubMed |
| Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signature. | Mol Genet Metab Rep | 2022 | 36420423 | PubTator, text mining | PubMed |
| dTMP imbalance through thymidylate 5'-phosphohydrolase activity induces apoptosis in triple-negative breast cancers. | Sci Rep | 2022 | 36414668 | PubTator, text mining | PubMed |
| Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review. | Heliyon | 2022 | 36406733 | PubTator, text mining | PubMed |
| Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment. | Front Immunol | 2022 | 36405681 | PubTator, text mining | PubMed |
| Recent advances in microbial production of L-malic acid. | Appl Microbiol Biotechnol | 2022 | 36370160 | PubTator, text mining | PubMed |
| Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. | J Neuropathol Exp Neurol | 2022 | 36367829 | PubTator, text mining | PubMed |
| Contemporary Drug Therapy for Renal Cell Carcinoma- Evidence Accumulation and Histological Implications in Treatment Strategy. | Biomedicines | 2022 | 36359359 | PubTator, text mining | PubMed |
| Electrophilic Aldehyde 4-Hydroxy-2-Nonenal Mediated Signaling and Mitochondrial Dysfunction. | Biomolecules | 2022 | 36358905 | PubTator, text mining | PubMed |
| Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy. | Cancers (Basel) | 2022 | 36358687 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism. | Antioxidants (Basel) | 2022 | 36358574 | PubTator, text mining | PubMed |
| Isotope-Assisted Metabolic Flux Analysis: A Powerful Technique to Gain New Insights into the Human Metabolome in Health and Disease. | Metabolites | 2022 | 36355149 | PubTator, text mining | PubMed |
| Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma. | iScience | 2022 | 36345344 | PubTator, text mining | PubMed |
| How New Developments Impact Diagnosis in Existing Renal Neoplasms. | Surg Pathol Clin | 2022 | 36344184 | PubTator, text mining | PubMed |
| Carcinoma of Unknown Original Identified as Renal Cell Carcinoma by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan: A Report of Two Cases. | Cureus | 2022 | 36337777 | PubTator, text mining | PubMed |
| Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC. | Front Oncol | 2022 | 36330476 | PubTator, text mining | PubMed |
| Case report: Ultrasonographic findings of retroperitoneum and abdominal wall metastases of renal cell carcinoma with FH gene deletion. | Front Oncol | 2022 | 36330469 | PubTator, text mining | PubMed |
| [Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma]. | Zhonghua Wai Ke Za Zhi | 2022 | 36323576 | PubTator, text mining | PubMed |
| Mitochondrial signal transduction. | Cell Metab | 2022 | 36323233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=30